Genetics News and Research

Latest Genetics News and Research

Study suggests that objective hearing tests need to be refined for teenagers at risk for hearing loss

Subjective screening questions do not reliably identify teenagers who are at risk for hearing loss, according to researchers at Penn State College of Medicine. The results suggest that objective hearing tests should be refined for this age group to replace screening questions.

26 Oct 2014

UT Southwestern receives CPRIT grant to expand genetic screening services in North Texas

Genetic screening services for rural and underserved populations will expand from six to 22 counties in North Texas under a $1.5 million grant from the Cancer Prevention and Research Institute of Texas to UT Southwestern Medical Center.

26 Oct 2014

High risk for congenital heart defects in Down syndrome provides tool to identify changes in genes

Down syndrome is the most common chromosomal abnormality in humans, involving a third copy of all or part of chromosome 21. In addition to intellectual disability, individuals with Down syndrome have a high risk of congenital heart defects. However, not all people with Down syndrome have them – about half have structurally normal hearts.

25 Oct 2014

MIT researchers develop new way to model effects of cancer-causing genetic mutations

Sequencing the genomes of tumor cells has revealed thousands of genetic mutations linked with cancer. However, sifting through this deluge of information to figure out which of these mutations actually drive cancer growth has proven to be a tedious, time-consuming process.

24 Oct 2014

French hospital uses Sophia DDM Platform to improve diagnostic testing of congenital disorders

The Hospices Civils de Lyon, the second-largest University Hospital Network in France, has elected to use the Sophia Genetics Data Driven Medicine (DDM) Platform to support improvements in diagnostic testing for patients suffering from congenital disorders.

24 Oct 2014

Human trial of second investigational Ebola vaccine candidate under way

Human testing of a second investigational Ebola vaccine candidate is under way at the National Institutes of Health's Clinical Center in Bethesda, Maryland.

23 Oct 2014

UH's Neurological Institute designated as Gold Center of Excellence

The Neurological Institute at University Hospitals has been designated as a Gold Center of Excellence (COE) and featured as a top performing center by NeuStrategy, Inc., a Chicago consulting firm providing strategic support to neuroscience, oncology and orthopaedic service providers.

23 Oct 2014

Genetics underpin bullying victimisation influence on paranoia

Bullying victimisation in childhood may indicate genetic risk for later psychosis, rather than being an environmental trigger, say UK researchers.

22 Oct 2014

Early access program for human chromosome mapping analytical service announced by Hitachi High-Technologies Corporation and OpGen

Hitachi High-Technologies Corporation and OpGen, Inc., a leading genetic analysis company, announced the introduction of an Early Access Program for its upcoming Human Chromosome ExplorerSM, human chromosome mapping analytical service for clinical research and life science research applications.

21 Oct 2014

Finding could help improve treatment of hearing loss caused by noise, normal aging

Scientists have restored the hearing of mice partly deafened by noise, using advanced tools to boost the production of a key protein in their ears.

21 Oct 2014

New study reveals how cancer becomes drug resistant over time

Like a colony of bacteria or species of animals, cancer cells within a tumor must evolve to survive. A dose of chemotherapy may kill hundreds of thousands of cancer cells, for example, but a single cell with a unique mutation can survive and quickly generate a new batch of drug-resistant cells, making cancer hard to combat.

21 Oct 2014

Directed Genomics, New England Biolabs to develop new technologies for NGS

New England Biolabs (NEB®) and Directed Genomics together announce that they have established a partnership to develop a suite of new technologies for next generation sequencing (NGS), including target enrichment.

From New England Biolabs 20 Oct 2014

Janssen announces submission of IMBRUVICA sNDA to FDA for WM treatment

Janssen Research & Development, LLC today announced the submission of a supplemental New Drug Application (sNDA) for IMBRUVICA (ibrutinib) to the U.S. Food and Drug Administration by its strategic partner Pharmacyclics, Inc.

20 Oct 2014

GENALICE launches all-in-one NGS data processing software solution, GENALICE MAP

Today, Dutch biomedical big data company GENALICE officially launched its all-in-one appliance for Next-Gen Sequencing (NGS) data processing, the GENALICE VAULT, at the annual conference of the American Society of Human Genetics.

20 Oct 2014

Regeneron, Sanofi announce initiation of dupilumab Phase 3 study in adults with atopic dermatitis

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the first patients have been dosed in a Phase 3 clinical study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, in adults with moderate-to-severe atopic dermatitis (AD) that is not adequately controlled with topical AD medications.

20 Oct 2014

Researchers identify genetic variant in Latina women that protects against breast cancer

An international research collaboration led by UC San Francisco researchers has identified a genetic variant common in Latina women that protects against breast cancer.

20 Oct 2014

Whole exome sequencing can assist in early diagnosis of various disorders

Approximately one-fourth of the 3,386 patients whose DNA was submitted for clinical whole exome testing received a diagnosis related to a known genetic disease, often ending a long search for answers for them and their parents, said researchers from the Baylor College of Medicine departments of molecular and human genetics and pediatrics and the Baylor Human Genome Sequencing Center and the University of Texas Health Science Center at Houston.

20 Oct 2014

Genome Canada awards $6M grant to CAMH and Assurex Health

Assurex Health and Canada's Centre for Addiction and Mental Health (CAMH) today announced they have received a $6 million grant from Genome Canada, an agency of the Canadian government, to study the benefits of genetic testing to guide medication decisions for patients with depression or schizophrenia.

17 Oct 2014

Amgen files lawsuit against Regeneron, Sanofi to prevent infringing manufacture of alirocumab

Amgen today announced that it filed a lawsuit in the United States (U.S.) District Court of Delaware against Sanofi, Aventisub LLC, formerly doing business as Aventis Pharmaceuticals Inc. (collectively "Sanofi"), and Regeneron Pharmaceuticals, Inc. ("Regeneron") for patent infringement of U.S. Patent Numbers 8,563,698, 8,829,165, and 8,859,741.

17 Oct 2014

New study to explore how NHS re-contacts patients with genetic information

A new study will be examining the implications of when and how NHS healthcare professionals re-contact patients with new genetic information that may impact their health or that of their family. The three year Economic and Social Research Council funded research will also explore issues of consent and how genetic information is stored.

16 Oct 2014

Genetics News and Research

Latest Genetics News and Research

Study suggests that objective hearing tests need to be refined for teenagers at risk for hearing loss

UT Southwestern receives CPRIT grant to expand genetic screening services in North Texas

High risk for congenital heart defects in Down syndrome provides tool to identify changes in genes

MIT researchers develop new way to model effects of cancer-causing genetic mutations

French hospital uses Sophia DDM Platform to improve diagnostic testing of congenital disorders

Human trial of second investigational Ebola vaccine candidate under way

UH's Neurological Institute designated as Gold Center of Excellence

Genetics underpin bullying victimisation influence on paranoia

Early access program for human chromosome mapping analytical service announced by Hitachi High-Technologies Corporation and OpGen

Finding could help improve treatment of hearing loss caused by noise, normal aging

New study reveals how cancer becomes drug resistant over time

Directed Genomics, New England Biolabs to develop new technologies for NGS

Janssen announces submission of IMBRUVICA sNDA to FDA for WM treatment

GENALICE launches all-in-one NGS data processing software solution, GENALICE MAP

Regeneron, Sanofi announce initiation of dupilumab Phase 3 study in adults with atopic dermatitis

Researchers identify genetic variant in Latina women that protects against breast cancer

Whole exome sequencing can assist in early diagnosis of various disorders

Genome Canada awards $6M grant to CAMH and Assurex Health

Amgen files lawsuit against Regeneron, Sanofi to prevent infringing manufacture of alirocumab

New study to explore how NHS re-contacts patients with genetic information

Sequencing & Genomics: Elevating Science and Healthcare eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging